C-reactive protein: An independent predictor of cardiovascular disease in Aboriginal Australians

Australian and New Zealand Journal of Public Health

Volumn 34, Issue SUPPL, 2010, Pages

  Wang, Zhiqiang ^a   Hoy, Wendy E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aboriginal; C reactive protein; Cardiovascular disease risk; Inflammation

Indexed keywords

C REACTIVE PROTEIN;

ABORIGINE; ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD; CARDIOVASCULAR DISEASE; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICS;

ADULT; AGED; AUSTRALIA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77956634035     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2010.00548.x     Document Type: Article

References (29)

1. Wang Z, Hoy WE. Population distribution of high sensitivity C-reactive protein values in Aboriginal Australians: a comparison with other populations. Clin Biochem. 2006;39(3):277-81.
2. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q, et al. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust. 2003;178(10):495-500. (Pubitemid 36637143)
3. McDonald S, Maguire G, Duarte N, Wang XL, Hoy W. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. Clin Sci. 2004;106(2):121-8. (Pubitemid 38223429)
4. National Centre for Monitoring Cardiovascular Disease. Heart, Stroke and Vascular Diseases - Australian Facts 2004. Canberra (AUST): Australian Institute of Health and Welfare.AIHW; 2004.
5. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005;182(2):66-9.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-9. (Pubitemid 27152782)
7. Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: evidence and clinical application. Curr Atheroscler Rep. 2003;5(5): 341-9. (Pubitemid 38898892)
8. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107(3):370-1.
9. Tall AR. C-reactive protein reassessed. N Engl J Med. 2004;350(14):1450-2. (Pubitemid 38420000)
10. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-97. (Pubitemid 38419992)
11. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102(18):2165-8.
12. Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PW, Li RK, et al. C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation. 2004;109(7):833-6. (Pubitemid 38252733)
13. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107(13):1783-90. (Pubitemid 36418360)
14. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-7.
15. Hoy WE, Wang Z, VanBuynder P, Baker PR, Mathews JD. The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time. Kidney Int. 2001;60(1):243-8. (Pubitemid 32587560)
16. STATA: statistical software [computer program]. Version 9.0. College Station (TX): StataCorp; 2005.
17. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2):237-42. (Pubitemid 29056365)
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-43. (Pubitemid 30165206)
19. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599-610. (Pubitemid 39628581)
20. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation. 2005;112(1): 25-31. (Pubitemid 40962565)
21. Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NJ, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003. Atherosclerosis. 2006;187(2):415-22. (Pubitemid 43963024)
22. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49(21):2129-38. (Pubitemid 46783865)
23. Wilson PW, Nam BH, Pencina M, D'Agostino RB Sr, Benjamin EJ, O'Donnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med. 2005;165(21):2473-8. (Pubitemid 41720008)
24. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031-41. (Pubitemid 40604084)
25. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006;440(7088):1217-21.
26. Jae SY, Fernhall B, Heffernan KS, Jeong M, Chun EM, Sung J, et al. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism. 2006;55(6):825-31. (Pubitemid 44255538)
27. Andersson J, Boman K, Jansson JH, Nilsson TK, Lindahl B. Effect of intensive lifestyle intervention on C-reactive protein in subjects with impaired glucose tolerance and obesity. Results from a randomized controlled trial with 5-year follow-up. Biomarkers. 2008;13(7):671-9.
28. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol. 2000;41(3): 139-45. (Pubitemid 30643953)
29. Carapetis J, Gardiner D, Currie B, Mathews JD. Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians. J Clin Microbiol. 1995;33(6):1471-2.